da Cunha-Bang, Caspar
Niemann, Carsten Utoft http://orcid.org/0000-0001-9880-5242
Funding for this research was provided by:
Novo Nordisk Fonden (NNF16OC0019302)
Kræftens Bekæmpelse (R-130-A8217-15-S38)
Article History
First Online: 3 November 2018
Compliance with Ethical Standards
:
: This study was funded by The Danish Cancer Society (Grant number R-130-A8217-15-S38) and The Novo Nordisk Foundation (Grant number NNF16OC0019302).
: Carsten Utoft Niemann has received grants from Janssen and Abbvie; consulting fees from Roche, Gilead, Janssen, Abbvie, AstraZeneca, and CSL Behring; and travel support to meetings from Roche, Gilead, Janssen, and Abbvie. Caspar da Cunha-Bang declares no conflicts of interest that might be relevant to the contents of this article.